首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 62 毫秒
1.
目的分析131Ⅰ治疗分化型甲状腺癌(DTC)合并远处转移患者的疗效和影响因素.方法152例DTC合并远端转移灶患者,经131Ⅰ清甲治疗后,133例患者接受了131Ⅰ阶段性长期治疗,平均剂量(172.3±22.4)mCi/次(1 mCi=37 MBq),131Ⅰ人均治疗(8.31±5.2)次,间隔(127±26)d,其余因转移灶不摄取131Ⅰ或其他并发症放弃131Ⅰ治疗.随访期1~10年.结果经131Ⅰ治疗后,37例(24.3%)治愈,82例病情好转或控制,总有效率为78.2%,其余无效或恶化.影响131Ⅰ疗效的主要因素包括转移灶的性质和部位、患者的年龄和131Ⅰ治疗的副反应.结论131Ⅰ是治疗DTC合并远处转移的有效手段,早期发现转移灶及控制131Ⅰ治疗的副反应是该治疗方法的关键.  相似文献   

2.
目的:评价大剂量131I治疗分化型甲状腺癌(DTC)术后及合并甲状腺外转移患者的疗效。方法:本文回顾性分析了197例DTC术后患者,清除甲状腺组织(简称"清甲")治疗69例,转移灶治疗128例。给药剂量:①清甲治疗组:常规给予131I3.7GBq清甲并辅以甲状腺素抑制治疗;②转移灶治疗组:首次清甲治疗后6个月,治疗淋巴结转移灶患者平均给予131I4.44GBq,治疗远处转移灶患者平均给予131I6.48GBq;并都辅以甲状腺素抑制治疗。以Tg,TgAb,颈部超声,肺部X-线,131I全身显像结果综合判定疗效。结果:清甲治疗组完全清除64例,完全清除率为92.8%(64/69);转移癌治疗组的治愈率57.8%(74/128)。结论:DTC术后行131I治疗,并辅甲状腺素抑制治疗疗效显著;淋巴结转移者的疗效高于远处转移者。  相似文献   

3.
目的:评价全反式维甲酸(ATRA)联合131Ⅰ治疗分化型甲状腺癌(DTC)失分化复发转移灶的疗效.方法:选择23例经甲状腺全切或次全切手术的DTC患者,且术后均经病理确诊,高度提示有失分化转移灶,采用口服ATRA 20 mg,3次/d,持续用药6周.比较ATRA诱导前、后转移灶摄取131Ⅰ变化并评价131Ⅰ治疗5个月后疗效.结果:21例D T C患者经ATRA诱导再分化治疗后,7例(33.3%)131Ⅰ摄取明显增高,10例(42.9%)轻度摄取增加,4例(19.1%)无变化.其中8例(38.1%)发现了新摄碘病灶.ATRA诱导再分化131Ⅰ治疗5个月后测病灶大小与治疗前比较13例患者中,4例(30.7%)缩小,6例(46.2%)无变化,3例(23.8%)增大.结论:ATRA诱导再分化治疗,对部分患者可使失分化细胞恢复或增加摄碘功能,进而可行131Ⅰ治疗,且副作用小.  相似文献   

4.
目的分析131Ⅰ治疗分化型甲状腺癌(DTC)肺转移的疗效及影响因素。方法回顾性分析124例确诊为DTC肺转移的病人给予相应剂量的131Ⅰ治疗,对年龄、性别、病理类型、局部淋巴结转移、肺外远处转移、清灶治疗前血甲状腺球蛋白(Tg)水平、手术方式、术后治疗时间和肺部摄取131Ⅰ形态等9个因素进行分析,评价131Ⅰ治疗疗效及影响因素。结果病人的年龄、清灶治疗前血Tg水平及肺外远处转移与疗效有关(P < 0.05~P < 0.01);经多因素分析,肺外远处转移是影响131Ⅰ治疗疗效的重要影响因素(P < 0.05)。结论131Ⅰ治疗DTC肺转移疗效较好,肺外远处转移是影响DTC肺转移疗效的确切因素。  相似文献   

5.
目的 回顾性分析放射性碘(131Ⅰ)治疗儿童和青少年分化型甲状腺癌(DTC)的特点及其疗效.方法 回顾性分析20例首次接受131Ⅰ治疗时年龄≤2l岁(5~21岁)DTC患者的临床及随访资料.20例患者中,乳头状癌18例.滤泡状癌2例;单纯淋巴结转移7例,肺转移8例.所有患者均接受131Ⅰ清除剩余甲状腺治疗;根据患者年龄、病情、转移灶位置以及病灶摄取131Ⅰ的程度等调整转移灶的131Ⅰ治疗剂量.以131Ⅰ全身显像、18F-FDG肿瘤显像及血清甲状腺球蛋白及其抗体水平评价疗效,同时观察不良反应发生情况.结果 中位随访时间为48.50个月(6~110月),患者生存率为100%.20例患者中,病灶消除13例,好转或稳定5例,无效或进展2例.7例单纯淋巴结转移患者消除4例,8例肺转移患者消除4例.随访期间未发生肺纤维化、继发肿瘤及生长发育异常等不良事件.结论 对于儿童和青少年DTC患者(尤其是已发生转移的患者),131Ⅰ是一种安全且有效的治疗方法 .  相似文献   

6.
目的 回顾性分析放射性碘(131Ⅰ)治疗儿童和青少年分化型甲状腺癌(DTC)的特点及其疗效.方法 回顾性分析20例首次接受131Ⅰ治疗时年龄≤2l岁(5~21岁)DTC患者的临床及随访资料.20例患者中,乳头状癌18例.滤泡状癌2例;单纯淋巴结转移7例,肺转移8例.所有患者均接受131Ⅰ清除剩余甲状腺治疗;根据患者年龄、病情、转移灶位置以及病灶摄取131Ⅰ的程度等调整转移灶的131Ⅰ治疗剂量.以131Ⅰ全身显像、18F-FDG肿瘤显像及血清甲状腺球蛋白及其抗体水平评价疗效,同时观察不良反应发生情况.结果 中位随访时间为48.50个月(6~110月),患者生存率为100%.20例患者中,病灶消除13例,好转或稳定5例,无效或进展2例.7例单纯淋巴结转移患者消除4例,8例肺转移患者消除4例.随访期间未发生肺纤维化、继发肿瘤及生长发育异常等不良事件.结论 对于儿童和青少年DTC患者(尤其是已发生转移的患者),131Ⅰ是一种安全且有效的治疗方法 .  相似文献   

7.
目的 通过对131I治疗DTC肺转移的回顾性研究,评价131I治疗DTC肺转移的疗效;结合疗效,对可能影响131I治疗DTC肺转移疗效的多种因素进行分析.方法 回顾性研究2004年9月至2007年3月期间在华西医院核医学科进行131I治疗的48例DTC肺转移患者,评价131I治疗DTC肺转移的疗效,对可能影响131I治疗DTC肺转移疗效的多种因素进行单因素和多因素分析.结果 按照131I治疗DTC肺转移的疗效评价标准,48例DTC肺转移患者治愈率10.5%、有效率62.5%、无效率37.5%.(1)单因素Logistic回归分析显示:年龄、胸部X线或CT、除肺之外的远处转移、确诊肺转移时的血Tg水平和肺摄取131I率等是影响131I治疗DTC肺转移疗效的因素;性别、肿瘤病理学类型、颈部淋巴结转移、残留甲状腺组织等时131I治疗DTC肺转移疗效无明显影响.(2)多因素逐步Logistic回归分析显示:远处转移、确诊肺转移时的血Tg水平和肺摄取131I率等是影响131I治疗DTC肺转移疗效的主要因素.结论 131I治疗DTC肺转移有较好的疗效.DTC肺转移患者中,无肺之外的远处转移、确诊时的血Tg水平低和肺摄取131I率高的患者1231I治疗效果好.总之,131I治疗DTC肺转移是一种安全有效的治疗方法,通过对131I治疗DTC肺转移疗效和影响因素的研究总结,对今后提高131I治疗效果有较好的指导意义.  相似文献   

8.
目的探讨碘-131(~(131)I)治疗分化型甲状腺癌(DTC)骨转移的临床效果及影响因素。方法选择2010年1月至2017年12月自贡市第一人民医院和重庆医科大学附属第二医院收治的86例DTC骨转移患者为研究对象,所有患者行甲状腺切除术,术后给予~(131)I治疗,每次~(131)I治疗前停用任何含碘药物,低碘饮食4周;首次给予~(131)I口服溶液3. 70~4. 81 GBq,空腹口服;以后根据患者病情及治疗反应情况给予第2次~(131)I口服液5. 55~7. 40 GBq;共治疗2~4次,连续治疗间隔时间为4~6个月,~(131)I累积剂量14. 80~34. 41 GBq。治疗后评估治疗效果,并分析治疗效果与患者临床病理特征的相关性。结果 86例DTC骨转移患者中,66例患者有骨痛症状,~(131)I治疗后55例骨痛缓解,11例未缓解,治疗有效率为83. 3%(55/66)。~(131)I清除DTC转移灶效果与患者年龄、性别、肿瘤病理类型及是否合并其他部位转移无相关性(P> 0. 05)。86例患者中,~(131)I清除DTC转移灶有效48例,无效38例,清除DTC转移灶有效率为55. 8%(48/86)。~(131)I清除DTC转移灶效果与患者年龄、肿瘤病理类型、肿瘤转移情况及癌组织中血管内皮生长因子(VEGF)表达水平有相关性(P <0. 05),而与患者性别无相关性(P> 0. 05)。结论 ~(131)I能够有效缓解DTC骨转移患者的骨痛症状,并对DTC转移灶清除有一定效果,但清除DTC转移灶效果与患者年龄、病理类型、是否合并其他部位转移及癌组织中VEGF表达水平密切相关。  相似文献   

9.
目的 探讨提高分化型甲状腺癌(DTC)复发灶或转移灶检出率的最优化核素显像方法 .方法 对89例DTC患者的临床资料进行回顾性分析.核素显像方法 包括血清甲状腺球蛋白(Tg)检查结合放射性碘(131Ⅰ)治疗剂量全身显像、99mTc-MIBI肿瘤显像和18F-FDG带符合线路的SPECT/CT全身显像,对三种核素显像的结果 进行对比分析.结果 131Ⅰ治疗剂量全身显像、99mTc-MIBI 肿瘤显像和18F-FDG带符合线路的SPECT/CT全身显像的灵敏度分别为83.05%、79.66%和16.95%.结论 99mTc-MIBI肿瘤显像和18F-FDG带符合线路的SPECT/CT全身显像作为补充检查手段,可弥补血清Tg检查结合131Ⅰ全身显像的局限性,对DTC患者复发灶或转移灶的检出、疗效评估及进一步治疗方案的制定具有重要意义.  相似文献   

10.
分化型甲状腺癌131I治疗中多种核素显像的联合应用   总被引:1,自引:0,他引:1       下载免费PDF全文
目的 探讨提高分化型甲状腺癌(DTC)复发灶或转移灶检出率的最优化核素显像方法 .方法 对89例DTC患者的临床资料进行回顾性分析.核素显像方法 包括血清甲状腺球蛋白(Tg)检查结合放射性碘(131Ⅰ)治疗剂量全身显像、99mTc-MIBI肿瘤显像和18F-FDG带符合线路的SPECT/CT全身显像,对三种核素显像的结果 进行对比分析.结果 131Ⅰ治疗剂量全身显像、99mTc-MIBI 肿瘤显像和18F-FDG带符合线路的SPECT/CT全身显像的灵敏度分别为83.05%、79.66%和16.95%.结论 99mTc-MIBI肿瘤显像和18F-FDG带符合线路的SPECT/CT全身显像作为补充检查手段,可弥补血清Tg检查结合131Ⅰ全身显像的局限性,对DTC患者复发灶或转移灶的检出、疗效评估及进一步治疗方案的制定具有重要意义.  相似文献   

11.
CASE HISTORY A female patient, 46 years old, head of the foreign affairs department of a certain university in Beijing, paid her first visit on October 9, 2006, with the chief complaint of vomiting for one month. She got vomiting after meals in early September. Before that, she had discomfortable sensation in the stomach due to angry with others, but she didn't pay much attention. Later, it developed into vomiting after eating. After the vomiting, the discomfort would be relieved, but with slight hypodynamia. She was once diagnosed as having 'neurogenic vomiting'. Having taken some western and Chinese drugs, the above symptoms were a little bit improved, but she would have nausea upon eating and with regurgitation. Because of the fear for vomiting, she did not dare to have food intake, with body weight reduction of 6 kilos in one month.  相似文献   

12.
Radiotherapy and chemotherapy are the important modern medical therapies for malignant tumors,yet they can also bring about serious local and systemic toxic side reactions so to decrease the patient;'s life quality,manifested by a series of consumptive symptoms.Having engaged in the combined work of Chinese and western medicine for nearly 50 years,the research fellow Qiu Baoguo in Henan Provincial Academy of TCM has developed his unique views on the TCM study of consumptive syndromes.The author of this essay had once the fortune tO follow Dr.Qiu in clinic,and specially would like to introduce in the following Dr.Qiu's experience in treating consumptive syndromes after radio-chemotherapies for patients with malignant tumor.  相似文献   

13.
OBJECTIVE: To observe therapeutic effects of the comprehensive therapy of acupuncture-moxibustion and Chinese Tuina for treatment of insomnia due to deficiency of both the heart and spleen. METHODS: 92 cases were divided randomly into the treatment group (treated by acupuncture-moxibustion and Chinese Tuina) and the control group (treated by acupuncture-moxibustion). RESULTS: The therapeutic effect of the treatment group was obviously superior to that of the control group (the CHI2 test showed P < 0.01). CONCLUSIONS: The comprehensive therapy of acupuncture-moxibustion and Chinese Tuina can give marked therapeutic effects for treatment of insomnia due to deficiency of both the heart and spleen.  相似文献   

14.
15.
Objective: To investigate if there are the CK-19, PDX-1, Nestin, Ngn3 positive cells in the donor islets of different purity in rats. Methods: Thirty male adult SD rats were randomly divided into 3 groups. Islets were isolated using digestion by ductal injection of collagenase. Group Ⅰ (n=10): Separating cell preparations were not purified, Group Ⅱ(n=10): Islet sediment was purified with 25% Ficoll400 ,Group Ⅲ (n=10): Islet sediment was purified with 25% and 11% Ficoll-400. The levels of protein of CK-19, PDX-1, Nestin and Ngn3 were detected by immunohistochemistry and the mRNA of CK-19, PDX-1, Nestin, Ngn3 was amplified by RT-PCR. Results: After two different purification methods applied, three islet preparations of different purities were obtained. The difference of islet purity was significant among various groups (P<0.05). Compared with group Ⅱ and group Ⅲ,the protein and mRNA of CK-19, PDX-1, Nestin,Ngn3 were both higher in group Ⅰ; group Ⅲ was poorly expressed. Conclusions: The three different islet purity donor islet have different CK-19, PDX-1, Nestin, Ngn3 positive cells within them, indicating that there are some islet stem cells in the purified donor islet.  相似文献   

16.
Objective:To investigate the optimum screening conditions of associated proteins in human psoriasis vulgaris by serum proteomics technique, and to screen the different expression proteins related with psoriasis vulgaris. Methods:Serum samples of peripheral blood were collected from newly diagnosed psoriasis vulgaris patients in the clinic, and 20 matched healthy persons. Serum albumin IgG was removed by filtering with ProteoExtract Albumin/IgG. After comparative proteomics analysis the different protein spots were identified using 2-DE and MS. Results :Electrophoresis figures with high resolution and reproducibility were obtained. Three different expression proteins were found only in the serum from psoriasis vulgaris patients, while nine other different proteins expressing from healthy volunteers. Conclusion:The protein expression was different in the serum between the psoriasis vulgaris patients and healthy volunteers. It was hoped that we could find the biomarkers related to psoriasis vulgaris by using proteomics.  相似文献   

17.
PYTOBEZOARS are common bezoars in gastrontestinal tract, commonly seen in stomach and mall intestine,1but huge disopyrobezoars are  相似文献   

18.
CASE HISTORY A male,a retired officer of 61 years old,paid his first visit on May 12,2006.The patient stated that 2 weeks before he suddenly got paroxysmal precordial choking pain,with irregular attacks.Each attack would last several seconds to several minutes.The attack was accompanied with heavy oppressed sensation in the precordial region,palpitation,lassitude,and in severe cases,sweating,which was once diagnosed by a hospital as'coronary heart disease'.Recalling the case history,the patient said that several days before he got angry with others because of some affairs in work,and he was not so used to the life pattern since he had just retired from his busy working post.At usual times,he was quick tempered and peevish.In recent days,he had poor appetite,and loose stool.  相似文献   

19.
20.
The English edition of Chinese Journal of Integrative Medicine is edited and published by the Chinese Journal of Integrated Traditional and Western Medicine Press.Original scientific papers of advanced clinical and experimental medicine in the field of complementary/alternative medicine or integrative medicine are expected.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号